Electroconvulsive therapy in catatonic patient infected with Sars-Cov-2

Código QR

Electroconvulsive therapy in catatonic patient infected with Sars-Cov-2

Guardado en:

Detalles Bibliográficos
Autores principales:	Jose Bustamante, Pablo Toro, Mario Bruna, Guillermo Bugedo
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/562675e91a854742bff43f2ef17e8aa1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The effectiveness of non-clozapine antipsychotics combined with electroconvulsive therapy versus clozapine combined with electroconvulsive therapy for treatment-resistant schizophrenia
por: Pichai Ittasakul, et al.
Publicado: (2021)

Vagus nerve stimulation in patients receiving maintenance therapy with electroconvulsive therapy: a series of 10 cases
por: Scott Aaronson, et al.
Publicado: (2021)

Computational model of electroconvulsive therapy considering electric field dependent skin conductivity
por: Gozde Unal, et al.
Publicado: (2021)

Real world evidence of age-independent electroconvulsive therapy efficacy: a retrospective cohort study
por: James Luccarelli, et al.
Publicado: (2021)

Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)
por: Bijan Zarrabi, et al.
Publicado: (2021)

Neuropsychological effects and attitudes in patients following electroconvulsive therapy
por: Miriam Feliu, et al.
Publicado: (2008)

Quantitative ictal electroencephalography (qEEG) comparison of Focal Electrically-Administered Seizure Therapy (FEAST) and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (UBP-RUL ECT)
por: Kevin Caulfield, et al.
Publicado: (2021)

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
por: Yoshimura B, et al.
Publicado: (2013)

Electroconvulsive therapy treatment in patients with somatic symptom and related disorders
por: Leong KW, et al.
Publicado: (2015)

Elongation of pulse width as an augmentation strategy in electroconvulsive therapy
por: Kawashima H, et al.
Publicado: (2014)

Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives
por: Lloyd JR, et al.
Publicado: (2020)

Medication management during electroconvulsant therapy
por: Zolezzi M
Publicado: (2016)

Cognitive functioning in patients treated with electroconvulsive therapy
por: Kalisova L, et al.
Publicado: (2018)

Balance and gait in older electroconvulsive therapy recipients: a pilot study
por: Plakiotis C, et al.
Publicado: (2013)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
por: Iancu I, et al.
Publicado: (2015)

Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study
por: Shibasaki C, et al.
Publicado: (2015)

The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study
por: Yasui-Furukori N, et al.
Publicado: (2014)

Telehealth transcranial direct current stimulation for recovery from Post-Acute Sequelae of SARS-CoV-2 (PASC)
por: Tehila Eilam-Stock, et al.
Publicado: (2021)

Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy
por: Joo SW, et al.
Publicado: (2017)

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia
por: Aksay SS, et al.
Publicado: (2017)

Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report
por: Mędrala T, et al.
Publicado: (2018)

Prevalence and Predictors of Postictal Confusion After Electroconvulsive Therapy
por: Ittasakul P, et al.
Publicado: (2021)

The Effect of Counseling on Stigma in Psychiatric Patients Receiving Electroconvulsive Therapy: A Clinical Trial Study
por: Sadeghian E, et al.
Publicado: (2019)

Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
por: Zincir S, et al.
Publicado: (2016)

N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection
por: Tsutsui K, et al.
Publicado: (2017)

Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study
por: Ittasakul P, et al.
Publicado: (2020)

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
por: Huang XB, et al.
Publicado: (2020)

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
por: Manoj K. Doss, et al.
Publicado: (2021)

Current state of electromagnetic neuromodulation therapy
por: Mark S. George
Publicado: (2021)

Current state of ultrasound neuromodulation therapy
por: Roland Beisteiner
Publicado: (2021)

Cellular mechanisms of electromagnetic neuromodulation therapy
por: Vincenzo DiLazzaro
Publicado: (2021)

TMS Therapy: What Does the Future Hold?
por: Linda Carpenter
Publicado: (2021)

Accelerated neuromodulation therapy for obsessive-compulsive disorder
por: Nolan Williams
Publicado: (2021)

VNS therapy for medically refractory partial seizures: An update
por: James W. Wheless
Publicado: (2021)

Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients
por: Ittasakul P, et al.
Publicado: (2019)

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients
por: Roulot M, et al.
Publicado: (2018)

The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder
por: Bian Z, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation therapy markedly reduces anxiety in adults with major depressive disorder: A retrospective analysis of 664 patients
por: Todd Hutton
Publicado: (2021)

Identification of a Personalized Intracranial Biomarker of Depression and Response to DBS Therapy
por: Adam Frank, et al.
Publicado: (2021)

Stanford neuromodulation therapy (SNT): a double-blinded, randomized, and controlled trial
por: Nolan Williams
Publicado: (2021)